St. John's Wort accelerates the liver clearance of technetium-99-sestamibi in rats

被引:3
作者
Mohammadinia, Salam [1 ,3 ]
Abedi, Seyed M. [2 ,3 ]
Noaparast, Zohreh [1 ,3 ]
机构
[1] Mazandaran Univ Med Sci, Fac Pharm, Dept Radiopharm, Sari, Iran
[2] Mazandaran Univ Med Sci, Fac Med, Dept Radiol, Sari, Iran
[3] Mazandaran Univ Med Sci, Pharmaceut Sci Res Ctr, Sari, Iran
关键词
technetium-99-sestamibi; image quality; liver clearance; myocardial perfusion imaging; St. John's Wort (Hypericum perforatum L.); P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; ABCB1; MDR1; IN-VITRO; DRUG; TC-99M-SESTAMIBI; SESTAMIBI; SUBSTRATE; TETROFOSMIN; EXPRESSION;
D O I
10.1097/MNM.0000000000000880
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundThe intense liver uptake of technetium-99-sestamibi (Tc-99m-MIBI) and photon scattering from the liver cause problems in quantitative perfusion interpretation. Hence, Tc-99m-MIBI is a substrate for P-glycoprotein pump; variations in P-glycoprotein levels may affect liver clearance.Methods and resultsAdult female Wistar rats were divided into seven main groups [control and St. John's Wort (SJW) treated] and each SJW-treated group included three subgroups that were killed at 15, 30, and 45min after Tc-99m-MIBI injection. Treated groups received an SJW extract suspension at two doses of 100 and 400mg/kg once daily for 5, 10, and 14 days, respectively. Tc-99m-MIBI was injected intravenously to all rats 24h after the final treatment. The rats were anesthetized at the mentioned time after tracer injection, and heart and liver tissues were removed, weighed, and their radioactivity was counted. One rat from each group was selected randomly for myocardial perfusion imaging. A significant increase in liver clearance and heart-to-liver ratio was observed in all SJW-treated groups compared with the control, especially at 10 days after SJW treatment. The heart radioactivity decreased in SJW-receiving groups at 14 days after SJW treatment.ConclusionThis study showed that SJW extract accelerates the liver clearance of Tc-99m-MIBI and significantly reduces photon scattering from the liver.
引用
收藏
页码:839 / 844
页数:6
相关论文
共 38 条
  • [21] Minimizing liver uptake of cationic Tc-99m radiotracers with ether and crown ether functional groups
    Kim, Young-Seung
    Wang, Fan
    Liu, Shuang
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2010, 2 (01) : 21 - 31
  • [22] Mechanism for myocardial localization and rapid liver clearance of Tc-99m-N-MPO: A new perfusion radiotracer for heart imaging
    Kim, Young-Seung
    Shi, Jiyun
    Zhai, Shizhen
    Hou, Guihua
    Liu, Shuang
    [J]. JOURNAL OF NUCLEAR CARDIOLOGY, 2009, 16 (04) : 571 - 579
  • [23] St. John's Wort - an Overview
    Linde, Klaus
    [J]. FORSCHENDE KOMPLEMENTARMEDIZIN, 2009, 16 (03): : 146 - 155
  • [24] Llaurado JG, 2001, J NUCL MED, V42, P282
  • [25] Lynch T, 2007, AM FAM PHYSICIAN, V76, P391
  • [26] Concise review: Clinical relevance of drug-drug and herb-drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein)
    Marchetti, Serena
    Mazzanti, Roberto
    Beijnen, Jos H.
    Schellens, Jan H. M.
    [J]. ONCOLOGIST, 2007, 12 (08) : 927 - 941
  • [27] Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: Effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging
    Merkel, Olivia M.
    Librizzi, Damiano
    Pfestroff, Andreas
    Schurrat, Tino
    Buyens, Kevin
    Sanders, Niek N.
    De Smedt, Stefaan C.
    Behe, Martin
    Kissel, Thomas
    [J]. JOURNAL OF CONTROLLED RELEASE, 2009, 138 (02) : 148 - 159
  • [28] Evaluating the safety of St. John's Wort in human pregnancy
    Moretti, Myla E.
    Maxson, Ashley
    Hanna, Fionna
    Koren, Gideon
    [J]. REPRODUCTIVE TOXICOLOGY, 2009, 28 (01) : 96 - 99
  • [29] In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumors
    Muzzammil, T
    Moore, MJ
    Ballinger, JR
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2000, 15 (04) : 339 - 346
  • [30] Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma
    Pusztai, L
    Wagner, P
    Ibrahim, N
    Rivera, E
    Theriault, R
    Booser, D
    Symmans, FW
    Wong, F
    Blumenschein, G
    Fleming, DR
    Rouzier, R
    Boniface, G
    Hortobagyi, GN
    [J]. CANCER, 2005, 104 (04) : 682 - 691